Hanmi Pharm. Co., Ltd.
128940.KSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
1,122
Cost of Revenue
509
Gross Profit
613
Gross Margin
54.6%
Operating Income
162
Operating Margin
14.5%
Net Income
91
Net Margin
8.1%
EPS (Basic)
$7.00
EPS (Diluted)
$7.00
EBITDA
220
EBITDA Margin
19.6%
2023
12/31/2023
Revenue
1,118
Cost of Revenue
496
Gross Profit
622
Gross Margin
55.6%
Operating Income
169
Operating Margin
15.1%
Net Income
110
Net Margin
9.8%
EPS (Basic)
$9.00
EPS (Diluted)
$9.00
EBITDA
243
EBITDA Margin
21.7%
2022
12/31/2022
Revenue
999
Cost of Revenue
460
Gross Profit
539
Gross Margin
54.0%
Operating Income
119
Operating Margin
11.9%
Net Income
62
Net Margin
6.2%
EPS (Basic)
$5.00
EPS (Diluted)
$5.00
EBITDA
187
EBITDA Margin
18.7%
2021
12/31/2021
Revenue
902
Cost of Revenue
428
Gross Profit
475
Gross Margin
52.6%
Operating Income
94
Operating Margin
10.4%
Net Income
50
Net Margin
5.6%
EPS (Basic)
$4.00
EPS (Diluted)
$4.00
EBITDA
157
EBITDA Margin
17.4%
2020
12/31/2020
Revenue
807
Cost of Revenue
371
Gross Profit
436
Gross Margin
54.0%
Operating Income
37
Operating Margin
4.6%
Net Income
9
Net Margin
1.1%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
81
EBITDA Margin
10.1%